- Investing Ideas
- /
- Swiss Top Stock Picks from Analysts
Swiss Top Stock Picks from Analysts
Results
29
4 new
Companies which are more than 50% undervalued based on analyst price target.
29 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
NEAG | CHF 34.20 | 1.8% | -13.0% | CHF 1.1b | CHF 65.00 | PE10.5x | E3.3% | 2.5% | Utilities | ||
COPN | CHF 62.70 | 0.5% | 58.3% | CHF 1.0b | CHF 97.30 | PE15.5x | E17.2% | 3.0% | Pharmaceuticals & Biotech | ||
LEHN | CHF 796.00 | 3.4% | -57.9% | CHF 906.6m | CHF 1,323.00 | PE29.7x | E36.9% | 6.3% | Tech | ||
MED | CHF 56.30 | 15.3% | -21.1% | CHF 765.4m | CHF 98.20 | PE189.8x | E53.9% | n/a | Healthcare | ||
AMS | CHF 5.57 | 1.0% | -65.4% | CHF 549.6m | CHF 10.55 | PS0.2x | E117.7% | 0% | Semiconductors | ||
VETN | CHF 26.90 | -2.9% | -25.1% | CHF 533.3m | CHF 43.67 | PE24.2x | E40.2% | 3.7% | Materials | ||
BSLN | CHF 40.85 | 1.2% | 16.4% | CHF 495.1m | CHF 77.25 | PS3.3x | E20.1% | 0% | Pharmaceuticals & Biotech | ||
LEON | CHF 23.80 | -3.3% | -40.7% | CHF 419.3m | CHF 40.00 | PE55.6x | E35.1% | 4.2% | Diversified Financials | ||
DOCM | CHF 29.66 | -3.6% | -49.2% | CHF 382.5m | CHF 52.33 | PS0.4x | E57.3% | 0% | Consumer Retailing | ||
RIEN New | CHF 84.90 | -2.4% | -4.1% | CHF 381.4m | CHF 130.00 | PE6.1x | E8.4% | 3.5% | Capital Goods | ||
MEDX | CHF 8.50 | -4.4% | -53.9% | CHF 346.7m | CHF 25.00 | PS0.7x | E59.6% | 5.9% | Healthcare | ||
VZUG | CHF 47.70 | 4.8% | -27.7% | CHF 306.6m | CHF 74.50 | PE19.1x | E38.7% | n/a | Consumer Durables | ||
MTG | CHF 26.50 | 0.6% | -27.5% | CHF 299.1m | CHF 45.00 | PE15.6x | E19.5% | 4.9% | Capital Goods | ||
VARN | CHF 27.00 | -0.4% | -27.2% | CHF 273.4m | CHF 43.58 | PS2.4x | S29.2% | 7.1% | Real Estate Management and Development | ||
MIKN New | CHF 13.50 | -4.6% | -2.5% | CHF 223.4m | CHF 22.00 | PE7.6x | n/a | 3.7% | Capital Goods | ||
MOLN | CHF 5.21 | 8.5% | 33.4% | CHF 192.1m | CHF 9.75 | PS32x | E-1.2% | n/a | Pharmaceuticals & Biotech | ||
LMN | CHF 16.50 | -2.9% | -31.7% | CHF 176.3m | CHF 25.02 | PE15.1x | E16.5% | 3.4% | Consumer Services | ||
BBN New | CHF 12.40 | -4.6% | -42.3% | CHF 163.1m | CHF 19.00 | PE11.1x | S3.8% | 9.3% | Diversified Financials | ||
ASCN | CHF 4.21 | 0.1% | -58.4% | CHF 151.2m | CHF 6.65 | PE9.9x | E11.5% | 7.1% | Healthcare | ||
IDIA | CHF 0.80 | 11.0% | -51.5% | CHF 151.0m | CHF 1.60 | PS2x | E15.1% | n/a | Pharmaceuticals & Biotech | ||
NWRN | CHF 7.50 | 7.1% | 54.6% | CHF 145.9m | CHF 14.42 | PS22.5x | E56.5% | n/a | Pharmaceuticals & Biotech | ||
MCHN New | CHF 4.00 | 0% | -5.0% | CHF 123.5m | CHF 6.00 | PS0.3x | E100.6% | 0% | Media | ||
KLIN | CHF 13.70 | 10.5% | -18.9% | CHF 121.1m | CHF 24.52 | PE9.1x | E12.9% | 3.5% | Capital Goods | ||
SANN | CHF 8.15 | -2.0% | -9.2% | CHF 98.7m | CHF 32.00 | PE1.6x | E35.4% | n/a | Pharmaceuticals & Biotech |